Test a new blood test for IgE allergy markers
Part of Immune system & allergy clinical trials.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 6 months old
- You have a proven IgE-type allergy (from skin testing and/or blood IgE test and/or allergy story)
- You can get current health/social coverage documents for the study
- You weigh at least 10 kg (for children)
- You are not pregnant and not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tissue samples to better understand allergies, asthma, and mast cell conditions. It aims to find markers that could improve diagnosis and treatment. Participation involves donating samples and sharing medical history.
This study looks at IgE, a protein involved in allergic reactions, to better understand its role in different immune-related diseases. It aims to find out how different forms of IgE relate to health and disease, which may help improve diagnosis or treatment.
This study looks for the biological reasons behind food allergies by collecting a small amount of blood. It may help scientists better understand different types of food allergy and eventually improve diagnosis or treatments.
This study is testing a new blood test for peanut allergy. If you join, you will give a few extra blood samples during a regular blood draw. The test may help doctors better diagnose peanut allergies.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This study uses a small microneedle patch to collect skin-related samples to help predict how well allergy immunotherapy may work. It includes people with house dust mite allergy and also a healthy control group, so researchers can compare biomarker results.
Hear when a new Allergy and Immunology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.